ASH Statement on HHS Restructure
Urging Thoughtful Reform: Prioritizing Patient Access, Innovative Research, and Hematology Progress in HHS Reorganization (WASHINGTON—March 28, 2025) – Yesterday, the Administration announced mass layoffs and wide-ranging restructuring o...
Read moreMachine Learning Program Enhances Transplant Risk Assessment in Myelofibrosis Patients
The open-access model shows that 25% of patients have 40% chance of dying within one year after transplant (WASHINGTON—March 27, 2025) — A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBM...
Read moreASH Significantly Expands Bridge Grant Eligibility
The changes offer increased opportunities and flexibility for researchers facing challenges in securing NIH funding in light of recent cutbacks to federal research support. (WASHINGTON—March 20, 2025) The ÈÈÃű¬ÁÏ (ASH) expande...
Read moreNo Scientific Link Found Between Sickle Cell Trait and Sudden Death
Expert panel’s findings refute attribution of sudden death to sickle cell trait (WASHINGTON—Jan. 30, 2025) – A systematic literature review found no evidence to support that physical exertion without rhabdomyolysis (muscle breakdo...
Read moreÈÈÃű¬ÁÏ Announces 2025 Scholar Award Recipients
ASH Scholar Award Celebrates 40 years of funding early-career hematology researchers (WASHINGTON, January 17, 2024) — The ÈÈÃű¬ÁÏ (ASH) announces the 35 recipients of its Scholar Awards for 2025. Now in its 40th ye...
Read moreBelinda Avalos, MD, Begins Term as 2025 ASH President
(WASHINGTON, Jan. 7, 2025) — Belinda Avalos, MD, professor of medicine and a senior advisor to the president of Atrium Health Levine Cancer, will serve as president of the ÈÈÃű¬ÁÏ (ASH) for a year-long term through Decemb...
Read moreHeightened Risk of Hospitalization for Blood Clots Seen in People with Long-Term Exposure to Air
Association seen regardless of participants’ smoking status and in those with no prior lung disease (WASHINGTON, Dec. 17, 2024) – People exposed to higher concentrations of three types of air pollution over a period of nearly 17 years ha...
Read moreUndergoing Stem Cell Transplant for Sickle Cell Disease in Childhood Improves Quality of Life a Decade Later
Transplant shows no difference in overall or progression-free survival compared with maintenance therapy alone LBA-6: Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Co...
Read moreStem Cell Transplant Offers No Additional Benefit for Patients with Mantle Cell Lymphoma in Deep Remission
Transplant recipients show better physical, school, and social functioning than those receiving transfusions and medications alone LBA-5: Outcome of Cerebral Vasculopathy and Cognitive Performances 10 Years Post-Enrollment in the Drepagreffe Trial Co...
Read moreGenetic Profile Correlates with Better Response to Treatment for Myeloproliferative Neoplasms
Variants could serve as biomarker to inform prognosis or guide treatment decisions LBA-4: Andean Enriched NFKB1 Haplotype Reduces Inflammation and Improves Response to Ropeginterferon Alfa-2b in Polycythemia Vera (PV) and Essential Thrombocythemia (E...
Read more- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10